longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Day One Biopharmaceuticals

DAWN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Servier agrees to acquire Day One Biopharmaceuticals for $2.5 billion, thereby entering the rare cancer field

    Wallstreetcn·Mar 6 at 02:47 PM
    DAWN0.00%
  • The Nasdaq Biotechnology Index closed up more than 1.4%, outperforming the major U.S. stock indices

    Wallstreetcn·Nov 5, 2025 at 10:03 PM
    VCYT-6.41%DAWN0.00%